Minerva Neurosciences Corp (NERV) Company Long-Term Loans and Borrowings

Symbol and logo of brand Minerva Neurosciences Corp (NERV)

The price action of Minerva Neurosciences (NERV) securities on the GURU.Markets platform reflects debt dynamics, which stand at 0.00. The business's financial stability relies on government contracts and insurance reimbursements for mental health disorder therapies. Minerva Neurosciences (NERV) retains leading neurobiologists through a stock option system and the high significance of its mission. Automated dosing systems and test result analysis software complement the technological stack.

NERV (Minerva Neurosciences, Inc.) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

NERV (Minerva Neurosciences Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price minervaneurosciences.com|NERV - Price Target Chart
- market capitalization data:
Market Value Minerva Neurosciences|NERV - Total Company Value
- book capitalization data:
Net Asset Value per Share Minerva Neurosciences|NERV - Company Book Value|Market Cap to Net Assets Ratio minervaneurosciences.com|NERV - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Minerva Neurosciences|NERV - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Minerva|NERV - Company Aggregate Debts|Debts to Book Value Minerva Neurosciences|NERV - Company Long-Term Debt|Company Short-Term Loans and Borrowings Minerva Neurosciences
Fundamental valuation:minervaneurosciences.com (NERV)
Manufactured products of minervaneurosciences.com

The development of roluperidone for the rehabilitation of patients with schizophrenia requires significant capital, making the analysis of long-term debt a key tool for assessing the financial stability of Minerva Neurosciences (NERV). The horizontal trend of this metric indicates planned debt servicing without new borrowings, which prevents the risk of a liquidity gap but may signal stagnant investment in operating activities.

Analysis of competing companies

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACAD (ACADIA Corp) - Long-Term Debt|Company Long-Term Debt XENE|Company Long-Term Liabilities vikingtherapeutics.com|SUPN (Supernus) - Company Long-Term Debts|Long-Term Debt Volume CPRX (Catalyst Pharma)|DNLI - Company Long-Term Debt|Company Long-Term Indebtedness Harmony Corp HRMY|BHVN (Biohaven Ltd.) - Company Long-Term Debts|AMLX: Long-Term Debt|Company Long-Term Debt Trevi Therapeutics, Inc. TRVI|Company Long-Term Loans and Borrowings Praxis Precision Medicines Inc|Company Long-Term Liabilities Anavex Corp|Company Long-Term Debt CeriBell EEG|Company Long-Term Debts PRTA|Company Long-Term Debts alector.com ALEC|Company Long-Term Liabilities Annexon|Omeros Corp - Company Long-Term Loans and Borrowings|Neurogene Corp (NGNE) - Company Long-Term Debt|ACIU - Company Long-Term Indebtedness|Company Long-Term Debts VYGR|Long-Term Debt neumoratx.com|SCLX (Scilex) - Company Long-Term Liabilities|Company Long-Term Debts TVGN|Alpha Cognition (ACOG) - Company Long-Term Debt|Company Long-Term Loans and Borrowings CGTX (cogrx.com)|IKT: Company Long-Term Debt|cassavasciences.com - Long-Term Debt|Company Long-Term Debt ASRT (Assertio Therapeutics)|COYA - Long-Term Debt Volume|VTGN (vistagen.com) - Company Long-Term Debts|Ovid Therapeutics (OVID) - Company Long-Term Liabilities|ABOS: Company Long-Term Debts|Long-Term Debt Volume cervomed.com|Alterity Therapeutics - Company Long-Term Debts|Long-Term Debt CLNN (clene.com)|PEPG - Company Long-Term Debt|Company Long-Term Indebtedness jupiterneurosciences.com JUNS|RLMD: Company Long-Term Debts|ANVS - Company Long-Term Liabilities|Company Long-Term Debts GRCE|AIFF (Firefly Neuroscience, Inc.) - Long-Term Debt|KLTO: Company Long-Term Debt|Long-Term Debt Volume NRSN|Company Long-Term Debt Reviva Pharmaceuticals RVPH|Company Long-Term Indebtedness metaviatx.com (MTVA)|NRXS: Company Long-Term Debts|Helius Medical Technologies, Inc. - Long-Term Debt|Company Long-Term Debt Passage Bio Corp (PASG)|Neuphoria Therapeutics Inc. (NEUP) - Company Long-Term Loans and Borrowings|Athira Pharma, Inc. (ATHA) - Company Long-Term Liabilities|ADXN (addextherapeutics.com) - Company Long-Term Debt|Company Long-Term Debt Alzamend Neuro Inc. (ALZN)|Company Long-Term Indebtedness Cyclerion|Protagenic Therapeutics - Company Long-Term Debts|Long-Term Debt pasitheaclinics.com KTTA|Company Long-Term Liabilities CRGT (Cortigent)|avenuetx.com - Company Long-Term Debts|Company Long-Term Debt BrainStorm Cell Therapeutics (BCLI)|CARA: Company Long-Term Loans and Borrowings|Company Long-Term Debt CHRO|ELYM (Eliem Therapeutics Inc.) - Long-Term Debt|Company Long-Term Debt ITCI|Company Long-Term Liabilities longboardpharma.com|MRNS (Marinus Pharmaceuticals, Inc.) - Company Long-Term Debts|Long-Term Debt Volume NKGN (NKGen Biotech Inc)|NRBO - Company Long-Term Debt|Company Long-Term Indebtedness Sage Therapeutics Inc SAGE|SNPX (Synaptogenix, Inc.) - Company Long-Term Debts|TRVN: Long-Term Debt|Company Long-Term Debt vigilneuro.com VIGL|Company Long-Term Loans and Borrowings Anew Medical Inc.|Company Long-Term Liabilities Cerevel